Next Article in Journal
Zinc Signaling in Acute Kidney Injury
Previous Article in Journal
Single-Cell and Bulk Transcriptomics Uncover the Cellular Ecosystem of Vascular Invasion in Intrahepatic Cholangiocarcinoma
 
 
Correction to Cells 2023, 12(7), 1040.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, Viale Stagno d’Alcontres, 31, 98166 Messina, Italy
*
Author to whom correspondence should be addressed.
Current Address: Department of Medicine and Surgery, UniCamillus—Saint Camillus International University of Health Sciences, Via di Sant’Alessandro, 8, 00131 Rome, Italy.
Cells 2026, 15(11), 1017; https://doi.org/10.3390/cells15111017
Submission received: 13 April 2026 / Accepted: 22 May 2026 / Published: 1 June 2026

Error in Figure

In the original publication [1], there was a mistake in Figure 3 as published. The mistake identified in Figure 3 (panels B3 and D2, respectively) is attributable to an unintentional error that occurred during the figure assembly. From the original raw data and source files, we confirm that the error was exclusively restricted to the assembly/presentation of the specific panel in Figure 3. The underlying experimental data used for quantification, normalization, statistical analysis, and graphical representation were generated independent of the mistakenly inserted image and were derived from the correct original datasets. Also, the quantification reported in Figure 3 was performed using the correct raw data; the statistical analyses associated with Figure 3 remain unchanged (1); no other figures, supplementary figures, or conclusions of the manuscript are affected by this error.
Therefore, the error does not impact the validity of the quantitative results, the interpretation of the experiment, or the overall conclusions of the study.
To ensure full transparency, we have corrected Figure 3. We have also carefully re-checked all figures in the manuscript to exclude the presence of additional assembly errors.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The revised Figure 3 appears below.

Reference

  1. Filippone, A.; Cucinotta, L.; Bova, V.; Lanza, M.; Casili, G.; Paterniti, I.; Campolo, M.; Cuzzocrea, S.; Esposito, E. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040. [Google Scholar] [CrossRef] [PubMed]
Figure 3. Immunohistochemical localization of NMDAR2B after mTBI in CA1, DG, PFC and amygdala areas. Yellow arrows indicate immunopositively neurons for NMDAR2B antibody. CA1 area: the non-mTBI group (A) and the mTBI group (A1), see percentage of NMDAR2B over the total tissue area (A4). PF-475 2.5 mg/kg (A2) and 5 mg/kg (A3), see percentage of NMDAR2B over the total tissue area (A4). DG area: the non-mTBI group (B) and the mTBI group (B1), see percentage of NMDAR2B over the total tissue area (B4). PF-475 2.5 mg/kg (B2) and 5 mg/kg (B3), see percentage of NMDAR2B over the total tissue area (B4). PFC area: the non-mTBI group (C) and the mTBI group (C1), see percentage of NMDAR2B over the total tissue area (C4). PF-475 2.5 mg/kg (C2) and 5 mg/kg (C3), see percentage of NMDAR2B over the total tissue area (C4). Amygdala area: the non-mTBI group (D) and the mTBI group (D1), see percentage of NMDAR2B over the total tissue area (D4). PF-475 2.5 mg/kg (D2) and 5 mg/kg (D3), percentage of NMDAR2B over the total tissue area (D4). The concentrations of GLT1 and GLAST in brain tissues (E,F). Data are expressed as SD from 10 mice for each group. Two-way ANOVA test. ** p < 0.01 and *** p < 0.001 vs. non mTBI; # p < 0.05, ## p < 0.01 and ### p < 0.001 vs. mTBI.
Figure 3. Immunohistochemical localization of NMDAR2B after mTBI in CA1, DG, PFC and amygdala areas. Yellow arrows indicate immunopositively neurons for NMDAR2B antibody. CA1 area: the non-mTBI group (A) and the mTBI group (A1), see percentage of NMDAR2B over the total tissue area (A4). PF-475 2.5 mg/kg (A2) and 5 mg/kg (A3), see percentage of NMDAR2B over the total tissue area (A4). DG area: the non-mTBI group (B) and the mTBI group (B1), see percentage of NMDAR2B over the total tissue area (B4). PF-475 2.5 mg/kg (B2) and 5 mg/kg (B3), see percentage of NMDAR2B over the total tissue area (B4). PFC area: the non-mTBI group (C) and the mTBI group (C1), see percentage of NMDAR2B over the total tissue area (C4). PF-475 2.5 mg/kg (C2) and 5 mg/kg (C3), see percentage of NMDAR2B over the total tissue area (C4). Amygdala area: the non-mTBI group (D) and the mTBI group (D1), see percentage of NMDAR2B over the total tissue area (D4). PF-475 2.5 mg/kg (D2) and 5 mg/kg (D3), percentage of NMDAR2B over the total tissue area (D4). The concentrations of GLT1 and GLAST in brain tissues (E,F). Data are expressed as SD from 10 mice for each group. Two-way ANOVA test. ** p < 0.01 and *** p < 0.001 vs. non mTBI; # p < 0.05, ## p < 0.01 and ### p < 0.001 vs. mTBI.
Cells 15 01017 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Filippone, A.; Cucinotta, L.; Bova, V.; Lanza, M.; Casili, G.; Paterniti, I.; Campolo, M.; Cuzzocrea, S.; Esposito, E. Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040. Cells 2026, 15, 1017. https://doi.org/10.3390/cells15111017

AMA Style

Filippone A, Cucinotta L, Bova V, Lanza M, Casili G, Paterniti I, Campolo M, Cuzzocrea S, Esposito E. Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040. Cells. 2026; 15(11):1017. https://doi.org/10.3390/cells15111017

Chicago/Turabian Style

Filippone, Alessia, Laura Cucinotta, Valentina Bova, Marika Lanza, Giovanna Casili, Irene Paterniti, Michela Campolo, Salvatore Cuzzocrea, and Emanuela Esposito. 2026. "Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040" Cells 15, no. 11: 1017. https://doi.org/10.3390/cells15111017

APA Style

Filippone, A., Cucinotta, L., Bova, V., Lanza, M., Casili, G., Paterniti, I., Campolo, M., Cuzzocrea, S., & Esposito, E. (2026). Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040. Cells, 15(11), 1017. https://doi.org/10.3390/cells15111017

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop